Enhanced protein production by engineered zinc finger proteins

Increasing the yield of therapeutic proteins from mammalian production cell lines reduces costs and decreases the time to market. To this end, we engineered a zinc finger protein transcription factor (ZFP TF) that binds a DNA sequence within the promoter driving transgene expression. This ZFP TF enabled >100% increase in protein yield from CHO cells in transient, stable, and fermentor production run settings. Expression vectors engineered to carry up to 10 ZFP binding sites further enhanced ZFP‐mediated increases in protein production up to ∼500%. The multimerized ZFP binding sites function independently of the promoter, and therefore across vector platforms. CHO cell lines stably expressing ZFP TFs demonstrated growth characteristics similar to parental cell lines. ZFP TF expression and gains in protein production were stable over >30 generations in the absence of antibiotic selection. Our results demonstrate that ZFP TFs can rapidly and stably increase protein production in mammalian cells. Biotechnol. Bioeng. 2007; 97: 1180–1189. © 2006 Wiley Periodicals, Inc.

[1]  Trisha Gura,et al.  Therapeutic antibodies: Magic bullets hit the target , 2002, Nature.

[2]  M. Rosser,et al.  High levels of protein expression using different mammalian CMV promoters in several cell lines. , 2006, Protein expression and purification.

[3]  T. Gerngross,et al.  Advances in the production of human therapeutic proteins in yeasts and filamentous fungi , 2004, Nature Biotechnology.

[4]  Mariangela Spitali,et al.  Therapeutic antibody fragments with prolonged in vivo half-lives , 1999, Nature Biotechnology.

[5]  C. Case,et al.  Validated Zinc Finger Protein Designs for All 16 GNN DNA Triplet Targets* , 2002, The Journal of Biological Chemistry.

[6]  Jun Ma,et al.  GAL4-VP16 is an unusually potent transcriptional activator , 1988, Nature.

[7]  D. Andersen,et al.  Recombinant protein expression for therapeutic applications. , 2002, Current opinion in biotechnology.

[8]  S. S. Olmsted,et al.  A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes , 1998, Nature Biotechnology.

[9]  L. Chasin,et al.  Effect of gamma rays at the dihydrofolate reductase locus: Deletions and inversions , 1986, Somatic cell and molecular genetics.

[10]  A. Otte,et al.  Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. , 2006, Trends in biotechnology.

[11]  Michael Boshart,et al.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus , 1985, Cell.

[12]  G. Chiang,et al.  A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity. , 2003, Journal of immunological methods.

[13]  A. Wolffe,et al.  Activation of Vascular Endothelial Growth Factor A Transcription in Tumorigenic Glioblastoma Cell Lines by an Enhancer with Cell Type-specific DNase I Accessibility* , 2002, The Journal of Biological Chemistry.

[14]  A. Klug,et al.  A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter , 2001, Nature Biotechnology.

[15]  Jeffrey C. Miller,et al.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases , 2005, Nature.

[16]  N. Mermod,et al.  Use of the chicken lysozyme 5' matrix attachment region to generate high producer CHO cell lines. , 2005, Biotechnology and bioengineering.

[17]  B. Osborne,et al.  Cloned transchromosomic calves producing human immunoglobulin , 2002, Nature Biotechnology.

[18]  David I. K. Martin,et al.  Chromatin insulation by a transcriptional activator , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C C Case,et al.  Regulation of an Endogenous Locus Using a Panel of Designed Zinc Finger Proteins Targeted to Accessible Chromatin Regions , 2001, The Journal of Biological Chemistry.

[20]  K. Arai,et al.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat , 1988, Molecular and cellular biology.

[21]  H. Scherthan,et al.  Gene Transfer and Amplification in CHO Cells , 1996, Annals of the New York Academy of Sciences.

[22]  M. Carey,et al.  A synergistic increase in potency of a multimerized VP16 transcriptional activation domain. , 1992, The EMBO journal.

[23]  Carl O. Pabo,et al.  Drug discovery with engineered zinc-finger proteins , 2003, Nature Reviews Drug Discovery.

[24]  J. Greenblatt,et al.  Three functional classes of transcriptional activation domain , 1996, Molecular and cellular biology.

[25]  C C Case,et al.  Synthetic Zinc Finger Transcription Factor Action at an Endogenous Chromosomal Site , 2000, The Journal of Biological Chemistry.

[26]  Seong-Il Lee,et al.  Identification and Use of Zinc Finger Transcription Factors That Increase Production of Recombinant Proteins in Yeast and Mammalian Cells , 2008, Biotechnology progress.

[27]  B. Peterlin,et al.  Synergistic Activation of Transcription by the Mutant and Wild-type Minimal Transcriptional Activation Domain of VP16 (*) , 1996, The Journal of Biological Chemistry.

[28]  F. Wurm.  Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.

[29]  M. Cockett,et al.  The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines. , 1991, Nucleic acids research.